Rapid Dipstick Test for Detection of IGFBP-1 as Indicator of Premature Rupture of Amniotic Fluid Membrane
- UID
- MFG/MD/2020/000208_3264cb10a5855042d3cc592022afcbe9_9d6492026086898dad49555d8ee41e1f
- Device class
- Class B
- Brand name
- EzDx Actim Partus
- License holder
- ADVY CHEMICAL PVT. LTD.
- Approving authority
- Kokan Division
- Product information
- The Rapid Dipstick Test for Detection of IGFBP-1 as Indicator of Premature Rupture of Amniotic Fluid Membrane is a visually interpreted, qualitative immunochromatographic dipstick test for detection of amniotic fluid in vaginal secretions during pregnancy. Actim PROM detects IGFBP-1, which is a major protein in amniotic fluid and a marker of the amniotic fluid in a vaginal sample. The test is intended for professional use to help diagnose the rupture of fetal membranes (EzDx Actim Partus ) in pregnant women.
Rapid Dipstick Test for Detection of IGFBP-1 as Indicator of Premature Rupture of Amniotic Fluid Membrane is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2020/000208_3264cb10a5855042d3cc592022afcbe9_9d6492026086898dad49555d8ee41e1f. This device is marketed under the brand name EzDx Actim Partus . The license holder is ADVY CHEMICAL PVT. LTD., and it is classified as Device Class Class B. The approving authority is Kokan Division.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.